Local anaesthetics: which benefit with the pure S enantiomers?;Anesthésiques locaux : qu'apportent les formes lévogyres ?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 25, Issue 4, 2006, Pages 408-412

  Mazoit, J X ^a   Baujard, C ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Levobupivacaine; Paediatric anaesthesia; Ropivacaine

Indexed keywords

LEVOBUPIVACAINE; LOCAL ANESTHETIC AGENT; ROPIVACAINE; AMIDE; BUPIVACAINE; DRUG DERIVATIVE; PLASMA PROTEIN;

ARTICLE; CARDIOTOXICITY; ENANTIOMER; HEART RATE; HUMAN; PEDIATRICS; PHARMACOLOGICAL PARAMETERS; REGIONAL ANESTHESIA; SAFETY; AGE; BLOOD VESSEL; CHEMISTRY; CHILD; DRUG EFFECT; ERYTHROCYTE; HEART; INFANT; METABOLIC CLEARANCE RATE; PRESCHOOL CHILD; REVIEW; STEREOISOMERISM;

AGE FACTORS; AMIDES; ANESTHETICS, LOCAL; BLOOD PROTEINS; BLOOD VESSELS; BUPIVACAINE; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; HEART; HEART RATE; HUMANS; INFANT; METABOLIC CLEARANCE RATE; STEREOISOMERISM;

EID: 33646043743     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2005.10.016     Document Type: Article

References (22)

1. Nau C., and Strichartz G.R. Drug chirality in anesthesia. Anesthesiology 97 (2002) 497-502
2. Mazoit J.X., and Dalens B.J. Pharmacokinetics of local anaesthetics in infants and children. Clin. Pharmacokinet. 43 (2004) 17-32
3. Meunier J.F., Goujard E., Dubousset A.M., Samii K., and Mazoit J.X. Pharmacokinetics of Bupivacaine after Continuous Epidural Infusion in Infants with and without Biliary Atresia. Anesthesiology 95 (2001) 87-95
4. Taheri S., Cogswell III L.P., Gent A., and Strichartz G.R. Hydrophobic and ionic factors in the binding of local anesthetics to the major variant of human alpha1-acid glycoprotein. J. Pharmacol. Exp. Ther. 304 (2003) 71-80
5. Mazoit J.X., Denson D.D., and Samii K. Pharmacokinetics of bupivacaine following caudal anesthesia in infants. Anesthesiology 68 (1988) 387-391
6. Booker P.D., Taylor C., and Saba G. Perioperative changes in alpha 1-acid glycoprotein concentrations in infants undergoing major surgery. Br. J. Anaesth. 76 (1996) 365-368
7. Mazoit J.X., Cao L.S., and Samii K. Binding of Bupivacaine to Human Serum Proteins, isolated Albumin and isolated alpha1-acid Glycoprotein. Differences between the two Enantiomers are partly due to Cooperativity. J. Pharmacol. Exp. Ther. 256 (1996) 109-115
8. Gantenbein M., Attolini L., Bruguerolle B., Villard P.H., Puyoou F., Durand A., et al. Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A. Drug Metab. Dispos. 28 (2000) 383-385
9. Oda Y., Furuichi K., Tanaka K., Hiroi T., Imaoka S., Asada A., et al. Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450. Anesthesiology 82 (1995) 214-220
10. Hines R.N., and McCarver D.G. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J. Pharmacol. Exp. Ther. 300 (2002) 355-360
11. Lonnqvist P.A., Westrin P., Larsson B.A., Olsson G.L., Lybeck A., Huledal G., et al. Ropivacaine pharmacokinetics after caudal block in 1-8-year-old children. Br. J. Anaesth. 85 (2000) 506-511
12. Rapp H.J., Molnar V., Austin S., Krohn S., Gadeke V., Motsch J., et al. Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block. Paediatr. Anaesth. 14 (2004) 724-732
13. Mazoit J.X., Decaux A., Bouaziz H., and Edouard A. Comparative ventricular electrophysiologic effect of racemic bupivacaine, levo bupivacaine and ropivacaine on the isolated rabbit heart. Anesthesiology 93 (2000) 784-792
14. Aya A.G., de La Coussaye J.E., Robert E., Ripart J., Cuvillon P., Mazoit J.X., et al. Comparison of the effects of racemic bupivacaine, levobupivacaine, and ropivacaine on ventricular conduction, refractoriness, and wavelength: an epicardial mapping study. Anesthesiology 96 (2002) 641-650
15. Simon L., Kariya N., Edouard A., Benhamou D., and Mazoit J.X. Effect of bupivacaine on the isolated rabbit heart: developmental aspect on ventricular conduction and contractility. Anesthesiology 101 (2004) 937-944
16. Lida H., Ohata H., Iida M., Nagase K., Uchida M., and Dohi S. The differential effects of stereoisomers of ropivacaine and bupivacaine on cerebral pial arterioles in dogs. Anesth. Analg. 93 (2001) 1552-1556
17. Mazoit J.X., and Dalens B. Ropivacaine in infants and children. Curr. Opin. Anaesthesiol. 16 (2003) 305-307
18. Mazoit J.X., and Baujard C. Paediatric caudal and epidural analgesia. Curr. Opin. Anaesthesiol. 15 (2002) 533-536
19. Bosenberg A., Thomas J., Lopez T., Lybeck A., Huizar K., and Larsson L.E. The efficacy of caudal ropivacaine 1, 2 and 3 mg x l(-1) for postoperative analgesia in children. Paediatr. Anaesth. 12 (2002) 53-58
20. Ivani G., DeNegri P., Conio A., Grossetti R., Vitale P., Vercellino C., et al. Comparison of racemic bupivacaine, ropivacaine, and levo-bupivacaine for pediatric caudal anesthesia: effects on postoperative analgesia and motor block. Reg. Anesth. Pain Med. 27 (2002) 157-161
21. Huet O., Eyrolle L.J., Mazoit J.X., and Ozier Y.M. Cardiac Arrest after Injection of ropivacaine for posterior lumbar plexus blockade. Anesthesiology 99 (2003) 1451-1453
22. Chazalon P., Tourtier J.P., Villevieille T., Giraud D., Saissy J.M., Mion G., et al. Ropivacaine-induced cardiac arrest after peripheral nerve block: successful resuscitation. Anesthesiology 99 (2003) 1449-1451